Adenocarcinoma Clinical Trials

A listing of Adenocarcinoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

UPDATED

Duarte California 91010

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

UPDATED

Encinitas California 92024

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

UPDATED

Los Angeles California 90033

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

UPDATED

Orange California 92868

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

UPDATED

Redondo Beach California 90277

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

View More ▼

UPDATED

Santa Monica California 90404

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

Colorado

UPDATED

Denver Colorado 80218

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

UPDATED

Denver Colorado 80218

Patients are needed to participate in a clinical research study of PEN-866

Connecticut

UPDATED

New Haven Connecticut 06520

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

Florida

UPDATED

Fort Lauderdale Florida 33308

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

UPDATED

Tampa Florida 33612-9416

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

Georgia

UPDATED

Athens Georgia 30607

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

UPDATED

Atlanta Georgia 30322

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

Illinois

UPDATED

Chicago Illinois 60611

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

UPDATED

Chicago Illinois 60637

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

UPDATED

Chicago Illinois 60637

A Phase 1 clinical study for patients using Selumetinib and Medi4736, Advanced Solid Tumors

UPDATED

Chicago Illinois 60637

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

UPDATED

Harvey Illinois 60426-3558

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

Indiana

UPDATED

Indianapolis Indiana 46250

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

Maryland

UPDATED

Baltimore Maryland 21287

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

UPDATED

Bethesda Maryland 20817

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

Massachusetts

UPDATED

Boston Massachusetts 02215

A Phase 1 clinical study for patients using Selumetinib and Medi4736, Advanced Solid Tumors

UPDATED

Rockland Massachusetts

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

Missouri

UPDATED

Bridgeton Missouri 63044

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

UPDATED

St. Louis Missouri 63110

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

New Jersey

UPDATED

Berkeley Heights New Jersey 07922

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

UPDATED

Hackensack New Jersey 07601

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

UPDATED

Midland Park New Jersey 07432

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

UPDATED

New Brunswick New Jersey 8901

A Phase 1 clinical study for patients using Selumetinib and Medi4736, Advanced Solid Tumors

New York

UPDATED

New York New York 10065

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

UPDATED

New York New York 10032

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

UPDATED

New York New York 10016

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

UPDATED

New York New York 10022

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

North Carolina

UPDATED

Charlotte North Carolina 28204

A Phase 1 clinical study for patients using Selumetinib and Medi4736, Advanced Solid Tumors

UPDATED

Huntersville North Carolina 28078

A Study of Epacadostat in Combination With a PD-1 Inhibitor and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207)

Ohio

UPDATED

Cincinnati Ohio 45229

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

UPDATED

Cleveland Ohio 44106

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

Oregon

UPDATED

Portland Oregon 97213

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

Pennsylvania

UPDATED

Philadelphia Pennsylvania 19111

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

UPDATED

Philadelphia Pennsylvania 19104

A Study of Epacadostat in Combination With a PD-1 Inhibitor and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207)

UPDATED

Pittsburgh Pennsylvania 15232

Patients are needed to participate in a clinical research study for the treatment of Pancreatic Ductal Adenocarcinoma

South Carolina

UPDATED

Greenville South Carolina 29605

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

Tennessee

UPDATED

Nashville Tennessee 37203

A clinical trial to evaluate treatments using MEDI4736 + Tremelimumab, MEDI4736 and Tremelimumab for patients with Gastric or Gastroesophageal Junction Adenocarcinoma

UPDATED

Nashville Tennessee 37232

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

UPDATED

Nashville Tennessee 37203

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV

UPDATED

Nashville Tennessee 37232

A Study of Epacadostat in Combination With a PD-1 Inhibitor and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207)

UPDATED

Nashville Tennessee 37232

Patients are needed to participate in a clinical research study evaluating Avelumab for the treatment of Adenocarcinoma

View More ▼

UPDATED

Nashville Tennessee 37203

Patients are needed to participate in a clinical research study for the treatment of Pancreatic Ductal Adenocarcinoma

UPDATED

Nashville Tennessee 37203

Patients are needed to participate in a clinical research study of PEN-866

Texas

UPDATED

Austin Texas 78731

A Phase 2 clinical study for patients with Lung Adenocarcinoma Stage IIIB/IV